Eisai Co Archives - Express Pharma

Eisai to grant 625 mn yen to GHIT Fund for developing medicines for neglected tropical diseases, malaria

Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease

Eisai enters into agreement with Blissbio for antibody-drug conjugate BB-1701

Biogen scraps two late-stage trials for Alzheimer’s treatment

DRL in agreement with Eisai Co, Japan